Serum GPX4 levels measured in the control group varied substantially; by contrast, the range was markedly smaller among those in the COPD group, with many of the measurements falling below the level of sensitivity of the assay (78.1 pg/mL). The gene discussed is GPX4; the disease is chronic obstructive pulmonary disease.